Quantum Genomics S.A.
QNNTF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | -$0 | $0 | $0 | $0 |
| % Growth | -199.5% | 17,033.3% | -99.9% | – |
| Cost of Goods Sold | $1 | $0 | $1 | $1 |
| Gross Profit | -$1 | -$0 | -$1 | -$1 |
| % Margin | 34,121.9% | -21,749.7% | -4,497,633.3% | -4,445.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | -$1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | -$1 | $1 | $1 | $1 |
| Operating Income | -$1 | -$1 | -$1 | -$2 |
| % Margin | 44,568.3% | -27,284.4% | -9,550,450% | -10,064.7% |
| Other Income/Exp. Net | -$4 | -$4 | -$0 | $0 |
| Pre-Tax Income | -$5 | -$4 | -$1 | -$2 |
| Tax Expense | $8 | -$8 | $0 | $0 |
| Net Income | -$1 | -$8 | -$1 | -$2 |
| % Margin | 33,069.6% | -399,610.9% | -9,877,900% | -10,036.4% |
| EPS | 0.11 | -0.24 | -0.034 | -0.057 |
| % Growth | 145.8% | -605.9% | 40.4% | – |
| EPS Diluted | 0.11 | -0.24 | -0.034 | -0.057 |
| Weighted Avg Shares Out | 70 | 35 | 35 | 34 |
| Weighted Avg Shares Out Dil | 70 | 35 | 35 | 34 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $7 | $7 | $0 | $0 |
| Depreciation & Amortization | $0 | -$0 | $0 | $0 |
| EBITDA | $7 | -$8 | -$1 | -$2 |
| % Margin | -330,295.9% | -399,029% | -8,451,416.7% | -10,042.1% |